Why Bioventus Inc. (BVS) stock fell 16.8% on Tuesday, November 3, 2026

Bioventus Inc. (BVS) closed at $10.95, down 16.77% on Tuesday, November 3, 2026, on volume of 2,444,868 shares (4.4× its 3-month average); market value about $700.0M.

What happened: primary sources

Events Nexqual found for BVS on Tuesday, November 3, 2026 or the trading day before (November 2, 2026):

• Nov 2, 2026: Reported Q3 2026 results: adjusted EPS $0.17 vs consensus $0.16 (beat), revenue $142.4M. Guidance: The company updated its 2026 net sales guidance to $590 million to $595 million and reaffirmed its adjusted EPS guidance of $0.75 to $0.79. source
• Nov 3, 2026: Canaccord Genuity: Target lowered, Buy, price target $19 → $18

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on BVS

BVS stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Earnings report: BVS results, November 2, 2026. Other big moves that day: November 3, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 4, 2026 at 09:50 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 4, 2026 at 09:50 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt